Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding changed +490.1% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Current liabilities changed +92.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current assets changed +184.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Total assets changed +181.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating income changed -107.9% from the comparable as-filed period.
Free-cash-flow proxy changed +39.2% from the comparable as-filed period.
Cash & equivalents changed -50.8% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating cash flow changed +39.0% from the comparable as-filed period.
Research & development changed +144.2% from the comparable as-filed period.
Current ratio changed +47.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital / assets changed +433 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Working capital changed +195.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capital expenditure changed -89.8% from the comparable as-filed period.
Stock-based compensation changed +23.8% from the comparable as-filed period.
Free-cash-flow proxy changed +27.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash flow changed +27.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Current liabilities changed -57.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current ratio changed +449.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Shares outstanding changed -53.3% from the comparable as-filed period. The change ranks at the 12th percentile of 8 prior comparable changes.
Operating income changed +82.6% from the comparable as-filed period.
Cash & equivalents changed -43.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Total assets changed +134.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital changed +208.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current assets changed +131.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Research & development changed -90.1% from the comparable as-filed period.
Working capital / assets changed +2244 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Stock-based compensation changed +409.7% from the comparable as-filed period.
Capital expenditure changed -21.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.